![](/img/cover-not-exists.png)
Role of Remission Status and Prior Transplant in Optimizing Survival Outcomes Following Allogeneic Hematopoietic Stem Transplantation (HSCT) in Patients Who Received Inotuzumab Ozogamicin for Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Kebriaei, Partow, Stelljes, Matthias, DeAngelo, Daniel J., Gökbuget, Nicola, Kantarjian, Hagop, Advani, Anjali S., Merchant, Akil, Stock, Wendy, Wang, Tao, Zhang, Hui, Loberiza, Fausto R., VandendriesVolume:
24
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2017.12.622
Date:
March, 2018
File:
PDF, 511 KB
english, 2018